Wednesday, September 28, 2022 | Back issues
Courthouse News Service Courthouse News Service

OxyContin Patent

MANHATTAN - A generic version of the blockbuster drug OxyContin did not infringe on Purdue Pharma's patent, a federal judge ruled, siding with the patent invalidity defense put forward by Teva Pharmaceuticals.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.